Cargando…

Correlation between treatment plan parameters and particular prognostic factors in prostate cancer treated with high–dose–rate brachytherapy (HDR–BT) as a boost

PURPOSE: Certain constraints for target coverage and dose limits in Organs at Risk (OARs) shows some evidence that doses values and homogeneity index in treated volume depends on prognostic factors such as prostate volume, location of urethra and the number of inserted applicators. Our study is to d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chicheł, Adam, Kanikowski, Marek, Skowronek, Janusz, Dymnicka, Magdalena, Piotrowski, Tomasz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2009
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080389/ https://www.ncbi.nlm.nih.gov/pubmed/27799948

Ejemplares similares

Vital role of volume and number of needles in HDR brachytherapy (HDR-BT) of prostate cancer
por: Chicheł, Adam, et al.
Publicado: (2009)

HDR brachytherapy (HDR–BT) combined with stent placement in palliative treatment of esophageal cancer
por: Kanikowski, Marek, et al.
Publicado: (2009)

HDR brachytherapy of prostate cancer – two years experience in Greater Poland Cancer Centre
por: Kanikowski, Marek, et al.
Publicado: (2009)

Hyperfractionation of HDR brachytherapy – influence on doses and biologically equivalent doses in clinical target volume and healthy tissues
por: Skowronek, Janusz, et al.
Publicado: (2009)

Time to PSA rise differentiates the PSA bounce after HDR and LDR brachytherapy of prostate cancer
por: Burchardt, Wojciech, et al.
Publicado: (2018)

Cosmetic effect in patients with early breast cancer treated with breast conserving therapy (BCT) and with HDR brachytherapy (HDR-BT) “boost”
por: Kulik, Anna, et al.
Publicado: (2009)

Comparison and verification of the reconstruction method of the catheters for interstitial brachytherapy
por: Blasiak, Barbara, et al.
Publicado: (2009)

Interstitial HDR brachytherapy (HDR-BT) in early stage mobile tongue cancers in young patients – Gliwice experience
por: Kellas-Ślęczka, Sylwia, et al.
Publicado: (2010)

Brachytherapy in breast cancer: an effective alternative
por: Skowronek, Janusz, et al.
Publicado: (2014)

Prostate brachytherapy: HDR or seed implant
por: Das, K. R.
Publicado: (2006)

Comparison of IPSA and HIPO inverse planning optimization algorithms for prostate HDR brachytherapy
por: Panettieri, Vanessa, et al.
Publicado: (2014)

The use of nomograms in LDR-HDR prostate brachytherapy
por: Pujades, Ma Carmen, et al.
Publicado: (2011)

MRS-guided HDR brachytherapy boost to the dominant intraprostatic lesion in high risk localised prostate cancer
por: Kazi, Aleksandra, et al.
Publicado: (2010)

External Validation of a Predictive Model of Urethral Strictures for Prostate Patients Treated With HDR Brachytherapy Boost
por: Panettieri, Vanessa, et al.
Publicado: (2020)

HDR Brachytherapy in the Management of High-Risk Prostate Cancer
por: Masson, Susan, et al.
Publicado: (2012)

Comparison of two planning systems for HDR brachytherapy gynecological application
por: Elhanafy, Osman A., et al.
Publicado: (2001)

Brachytherapy in the therapy of prostate cancer – an interesting choice
por: Skowronek, Janusz
Publicado: (2013)

Interactive, multi-modality image registrations for combined MRI/MRSI-planned HDR prostate brachytherapy
por: Reed, Galen, et al.
Publicado: (2011)

A case of CRPC with multiple bladder invasions treated with EBRT followed by HDR-BT boost
por: Takagawa, Yoshiaki, et al.
Publicado: (2022)

Corrigendum to “HDR Brachytherapy in the Management of High-Risk Prostate Cancer”
por: Masson, Susan, et al.
Publicado: (2016)

MR-guided HDR prostate brachytherapy with teleoperated steerable needles
por: de Vries, M., et al.
Publicado: (2023)

Influence of length of interval between pulses in PDR brachytherapy (PDRBT) on value of Biologically Equivalent Dose (BED) in healthy tissues
por: Skowronek, Janusz, et al.
Publicado: (2010)

Trans-hepatic technique and intraluminal Pulsed Dose Rate (PDR-BT) brachytherapy in treatment of locally advanced bile duct and pancreas cancer
por: Skowronek, Janusz, et al.
Publicado: (2009)

HDR brachytherapy as a solution in recurrences of locally advanced prostate cancer
por: Łyczek, Jarosław, et al.
Publicado: (2009)

MRI‐TRUS registration methodology for TRUS‐guided HDR prostate brachytherapy
por: McGeachy, Philip, et al.
Publicado: (2021)

A comprehensive evaluation of adaptive daily planning for cervical cancer HDR brachytherapy
por: Meerschaert, Rebecca, et al.
Publicado: (2016)

A Brief Review of Low-Dose Rate (LDR) and High-Dose Rate (HDR) Brachytherapy Boost for High-Risk Prostate
por: Fischer-Valuck, Benjamin W., et al.
Publicado: (2019)

Film based verification of calculation algorithms used for brachytherapy planning-getting ready for upcoming challenges of MBDCA
por: Zwierzchowski, Grzegorz, et al.
Publicado: (2016)

Dosimetric analysis and comparison of IMRT and HDR brachytherapy in treatment of localized prostate cancer
por: Murali, V., et al.
Publicado: (2010)

The emerging role of high-dose-rate (HDR) brachytherapy as monotherapy for prostate cancer
por: Yoshioka, Yasuo, et al.
Publicado: (2013)

Implementation of a real‐time, ultrasound‐guided prostate HDR brachytherapy program
por: Smith, Blake R., et al.
Publicado: (2021)

Focal HDR brachytherapy boost to stereotactic radiotherapy (fBTsRT) for prostate cancer: a phase II randomized controlled trial
por: Belliveau, C., et al.
Publicado: (2022)

Dose correction in lung for HDR breast brachytherapy
por: Slessinger, Eric, et al.
Publicado: (2012)

Development of an HDR‐BT QA tool for source position verification
por: Kumazaki, Yu, et al.
Publicado: (2020)

Systematic Review of Focal Prostate Brachytherapy and the Future Implementation of Image-Guided Prostate HDR Brachytherapy Using MR-Ultrasound Fusion
por: Peach, M. Sean, et al.
Publicado: (2016)

Low-dose-rate or high-dose-rate brachytherapy in treatment of prostate cancer – between options
por: Skowronek, Janusz
Publicado: (2013)

Comparison of Oncentra® Brachy IPSA and graphical optimisation techniques: a case study of HDR brachytherapy head and neck and prostate plans
por: Jameson, Michael G, et al.
Publicado: (2015)

Evaluation of hybrid inverse planning and optimization (HIPO) algorithm for optimization in real‐time, high‐dose‐rate (HDR) brachytherapy for prostate
por: Pokharel, Shyam, et al.
Publicado: (2013)

HDR prostate brachytherapy plan robustness and its effect on in‐vivo source tracking error thresholds: A multi‐institutional study
por: Poder, Joel, et al.
Publicado: (2022)

Dosimetric comparison of surface mould HDR brachytherapy with VMAT
por: Boman, Eeva L., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jdm7kks2lu4lsmitf345anmthk